Evaluation of gene therapy as an intervention strategy to treat brain injury from stroke

Frontiers in Molecular Neuroscience

Volumn 9, Issue MAY, 2016, Pages

  Craig, Amanda J ^a   Housley, Gary D ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

AAV; Adeno; Herpes simplex virus; Ischemia; Lentivirus; Protein expression; Viral vector

Indexed keywords

ANTIOXIDANT; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CILIARY NEUROTROPHIC FACTOR; GENE THERAPY AGENT; GLUTATHIONE PEROXIDASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; NEUROTROPHIN; PROTEIN BAX; PROTEIN BCL 2; STROMAL CELL DERIVED FACTOR 1; SUPEROXIDE DISMUTASE; VIRUS VECTOR;

BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; EXCITOTOXICITY; GENE CASSETTE; GENE TARGETING; GENE THERAPY; HUMAN; NEUROPROTECTION; NONHUMAN; PROTEIN SYNTHESIS; REVIEW; STEM CELL TRANSPLANTATION; VIRAL GENE DELIVERY SYSTEM;

EID: 84971264666     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2016.00034     Document Type: Review

References (85)

1. Akli, S., Caillaud, C., Vigne, E., Stratford-Perricaudet, L. D., Poenaru, L., Perricaudet, M., et al. (1993). Transfer of a foreign gene into the brain using adenovirus vectors. Nat. Genet. 3, 224-228. doi: 10.1038/ng0393-224
2. Andsberg, G., Kokaia, Z., Klein, R. L., Muzyczka, N., Lindvall, O., andMandel, R. J. (2002). Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats. Neurobiol. Dis. 9, 187-204. doi: 10.1006/nbdi.2001.0456
3. Arvidsson, A., Kirik, D., Lundberg, C.,Mandel, R. J., Andsberg, G., Kokaia, Z., et al. (2003). Elevated GDNF levels following viral vector-mediated gene transfer can increase neuronal death after stroke in rats. Neurobiol. Dis. 14, 542-556. doi: 10.1016/j.nbd.2003.08.002
4. Badin, R. A., Lythgoe, M. F., van der Weerd, L., Thomas, D. L., Gadian, D. G., and Latchman, D. S. (2006). Neuroprotective effects of virally delivered HSPs in experimental stroke. J. Cereb. Blood Flow Metab. 26, 371-381. doi: 10.1038/sj.jcbfm.9600190
5. Badin, R. A., Modo, M., Cheetham, M., Thomas, D. L., Gadian, D. G., Latchman, D. S., et al. (2009). Protective effect of post-ischaemic viral delivery of heat shock proteins in vivo. J. Cereb. Blood Flow Metab. 29, 254-263. doi: 10.1038/jcbfm.2008.106
6. Banks, P., Franks, N. P., and Dickinson, R. (2010). Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia. Anesthesiology 112, 614-622. doi: 10.1097/ALN.0b013e3181cea398
7. Bloom, D. C., Maidment, N. T., Tan, A., Dissette, V. B., Feldman, L. T., and Stevens, J. G. (1995). Long-term expression of a reporter gene from latent herpes simplex virus in the rat hippocampus. Brain Res. Mol. Brain Res. 31, 48-60. doi: 10.1016/0169-328x(95)00031-m
8. Brea, D., Agulla, J., Staes, A., Gevaert, K., Campos, F., Sobrino, T., et al. (2015). Study of protein expresion in peri-infarct tissue after cerebral ischemia. Sci. Rep. 5: 12030. doi: 10.1038/srep12030
9. Broderick, J. P., Palesch, Y. Y., Demchuk, A. M., Yeatts, S. D., Khatri, P., Hill, M. D., et al. (2013). Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N. Engl. J. Med. 368, 893-903. doi: 10.1056/NEJMoa1214300
10. Carpenter, D. E., and Stevens, J. G. (1996). Long-term expression of a foreign gene from a unique position in the latent herpes simplex virus genome. Hum. Gene Ther. 7, 1447-1454. doi: 10.1089/hum.1996.7.12-1447
11. Chan, P. H., Kawase, M., Murakami, K., Chen, S. F., Li, Y., Calagui, B., et al. (1998). Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J. Neurosci. 18, 8292-8299.
12. Chen, B., Zhang, F., Li, Q.-Y., Gong, A., and Lan, Q. (2016). Protective effect of Ad-VEGF-Bone mesenchymal stem cells on cerebral infarction. Turk. Neurosurg. 26, 8-15. doi: 10.5137/1019-5149.jtn.11488-14.3
13. Cheng, X., Lian, Y., Ma, Y., Xie, N., and Wu, C. (2016). Elevated serum levels of CXC Chemokine Ligand-12 are associated with unfavorable functional outcome and mortality at 6-month follow-up in chinese patients with acute ischemic stroke. Mol. Neurobiol. doi: 10.1007/s12035-015-9645-9 [Epub ahead of print].
14. Czabotar, P. E., Lessene, G., Strasser, A., and Adams, J. M. (2014). Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 15, 49-63. doi: 10.1038/nrm3722
15. Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., et al. (2000). Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. U.S.A. 97, 3428-3432. doi: 10.1073/pnas.050581197
16. de Los Rios la Rosa, F., Khoury, J., Kissela, B. M., Flaherty, M. L., Alwell, K., Moomaw, C. J., et al. (2012). Eligibility for intravenous recombinant tissuetype plasminogen activator within a population: the effect of the european cooperative acute stroke study (ECASS) III trial. Stroke 43, 1591-1595. doi: 10.1161/strokeaha.111.645986
17. Dirnagl, U., Iadecola, C., and Moskowitz, M. A. (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397. doi: 10.1016/S0166-2236(99)01401-0
18. Duricki, D. A., Hutson, T. H., Kathe, C., Soleman, S., Gonzalez-Carter, D., Petruska, J. C., et al. (2016). Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke. Brain 139, 259-275. doi: 10.1093/brain/awv341
19. Emberson, J., Lees, K. R., Lyden, P., Blackwell, L., Albers, G., Bluhmki, E., et al. (2014). Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a metaanalysis of individual patient data from randomised trials. Lancet 384, 1929-1935. doi: 10.1016/s0140-6736(14)60584-5
20. García-Berrocoso, T., Giralt, D., Llombart, V., Bustamante, A., Penalba, A., Flores, A., et al. (2014). Chemokines after human ischemic stroke: from neurovascular unit to blood using protein arrays. Transl. Proteom. 3, 1-9. doi: 10.1016/j.trprot.2014.03.001
21. Hallek, M., and Wendtner, C. M. (1996). Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications. Cytokines Mol. Ther. 2, 69-79.
22. Harvey, B. K., Chang, C. F., Chiang, Y. H., Bowers, W. J., Morales, M., Hoffer, B. J., et al. (2003). HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Exp. Neurol. 183, 47-55. doi: 10.1016/S0014-4886(03)00080-3
23. Hermann, D. M., Kilic, E., Kugler, S., Isenmann, S., and Bahr, M. (2001a). Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol. Dis. 8, 655-666. doi: 10.1006/nbdi.2001.0399
24. Hermann, D. M., Kilic, E., Kugler, S., Isenmann, S., and Bahr, M. (2001b). Adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) expression protects against subsequent cortical cold injury in rats. Neurobiol. Dis. 8, 964-973. doi: 10.1006/nbdi.2001.0448
25. Hoehn, B., Ringer, T. M., Xu, L., Giffard, R. G., Sapolsky, R. M., Steinberg, G. K., et al. (2001). Overexpression of HSP72 after induction of experimental stroke protects neurons from ischemic damage. J. Cereb. Blood Flow Metab. 21, 1303-1309. doi: 10.1097/00004647-200111000-00006
26. Hoehn, B., Yenari, M. A., Sapolsky, R. M., and Steinberg, G. K. (2003). Glutathione peroxidase overexpression inhibits cytochrome c release and proapoptotic mediators to protect neurons from experimental stroke. Stroke 34, 2489-2494. doi: 10.1161/01.str.0000091268.25816.19
27. Jeong, H., Yim, H. W., Cho, Y.-S., Kim, Y.-I., Jeong, S.-N., Kim, H.-B., et al. (2014). Efficacy and safety of stem cell therapies for patients with stroke: a systematic review and single arm meta-analysis. Int. J. Stem Cells 7, 63-69. doi: 10.15283/ijsc.2014.7.2.63
28. Kane, D., Sarafian, T., Anton, R., Hahn, H., Gralla, E., Valentine, J., et al. (1993). Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262, 1274-1277. doi: 10.1126/science.8235659
29. Kawase, M., Murakami, K., Fujimura, M., Morita-Fujimura, Y., Gasche, Y., Kondo, T., et al. (1999). Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency. Stroke 30, 1962-1968. doi: 10.1161/01.str.30.9.1962
30. Kelly, S., Zhang, Z., Zhao, H., Xu, L., Giffard, R., Sapolsky, R., et al. (2002). Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann. Neurol. 52, 160-167. doi: 10.1002/ana.10264
31. Kilic, E., Hermann, D. M., Kügler, S., Kilic, U., Holzmüller, H., Schmeer, C., et al. (2002). Adenovirus-mediated Bcl-X(L) expression using a neuron-specific synapsin-1 promoter protects against disseminated neuronal injury and brain infarction following focal cerebral ischemia in mice. Neurobiol. Dis. 11, 275-284. doi: 10.1006/nbdi.2002.0552
32. Kitagawa, K., Matsumoto, M., Tsujimoto, Y., Ohtsuki, T., Kuwabara, K., Matsushita, K., et al. (1998). Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke 29, 2616-2621. doi: 10.1161/01.str.29.12.2616
33. Kleihues, P., and Hossmann, K. (1971). Protein synthesis in the cat brain after prolonged cerebral ischemia. Brain Res. 35, 409-418. doi: 10.1016/0006-8993(71)90484-7
34. Lawrence, M. S., McLaughlin, J. R., Sun, G. H., Ho, D. Y., McIntosh, L., Kunis, D. M., et al. (1997). Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J. Cereb. Blood Flow Metab. 17, 740-744. doi: 10.1097/00004647-199707000-00003
35. Lee, J., Hong, J., Moon, G., Lee, P., Ahn, Y., and Bang, O. (2010). A longterm follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem cells 28, 1099-1106. doi: 10.1002/stem.430
36. Lei, Z., Liu, F., Zhang, L., Huang, Y., and Sun, F. (2012). Bcl-2 increases strokeinduced striatal neurogenesis in adult brains by inhibiting BMP-4 function via activation of beta-catenin signaling. Neurochem. Int. 61, 34-42. doi: 10.1016/j.neuint.2012.04.004
37. Li, Y., Huang, J., He, X., Tang, G., Tang, Y. H., Liu, Y., et al. (2014). Postacute stromal cell-derived factor-1alpha expression promotes neurovascular recovery in ischemic mice. Stroke 45, 1822-1829. doi: 10.1161/strokeaha.114.005078
38. Li, Y., Tang, G., Liu, Y., He, X., Huang, J., Lin, X., et al. (2015). CXCL12 gene therapy ameliorates ischemia-induced white matter injury in mouse brain. Stem Cells Transl. Med. 4, 1122-1130. doi: 10.5966/sctm.2015-0074
39. Lindholm, P., Voutilainen, M. H., Lauren, J., Peranen, J., Leppanen, V.-M., Andressoo, J.-O., et al. (2007). Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature 448, 73-77. doi: 10.1038/nature05957
40. Linnik, M. D., Zahos, P., Geschwind, M. D., and Federoff, H. J. (1995). Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 26, 1670-1674: discussion 5. doi: 10.1161/01.str.26.9.1670
41. Liu, P., Xiang, J.-W., and Jin, S.-X. (2015). Serum CXCL12 levels are associated with stroke severity and lesion volumes in stroke patients. Neurolog. Res. 37, 853-858. doi: 10.1179/1743132815Y.0000000063
42. Machalinski, B. (2014). Tissue regeneration in stroke: cellular and trophic mechanisms. Expert Rev. Neurotherapeutics 14, 959-969. doi: 10.1586/14737175.2014.939172
43. Madsen, T. E., Khoury, J. C., Alwell, K. A., Moomaw, C. J., Kissela, B. M., De Los Rios La Rosa, F., et al. (2015). Analysis of tissue plasminogen activator eligibility by sex in the Greater Cincinnati/Northern Kentucky stroke study. Stroke 46, 717-721. doi: 10.1161/strokeaha.114.006737
44. Mason, M. R. J., Ehlert, E. M. E., Eggers, R., Pool, C. W., Hermening, S., Huseinovic, A., et al. (2010). Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons. Mol. Ther. 18, 715-724. doi: 10.1038/mt.2010.19
45. Matlik, K., Abo-Ramadan, U., Harvey, B. K., Arumae, U., and Airavaara, M. (2014). AAV-mediated targeting of gene expression to the peri-infarct region in rat cortical stroke model. J. Neurosci. Methods 236, 107-113. doi: 10.1016/j.jneumeth.2014.08.014
46. Moore, S., Tessier-Lavigne, M., and Kennedy, T. (2007). Netrins and their receptors. Adv. Exp. Med. Biol. 621, 17-31. doi: 10.1007/978-0-387-76715-4_2
47. Moretti, A., Ferrari, F., and Villa, R. F. (2015). Neuroprotection for ischaemic stroke: current status and challenges. Pharmacol. Ther. 146, 23-34. doi: 10.1016/j.pharmthera.2014.09.003
48. Moskowitz, M. A., Lo, E. H., and Iadecola, C. (2010). The science of stroke: mechanisms in search of treatments. Neuron 67, 181-198. doi: 10.1016/j.neuron.2010.07.002
49. Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., et al. (2015). Heart disease and stroke statistics-2015 update: a report from the american heart association. Circulation 131, e29-e322. doi: 10.1161/cir.0000000000000152
50. Murakami, K., Kondo, T., Epstein, C. J., and Chan, P. H. (1997). Overexpression of CuZn-Superoxide dismutase reduces hippocampal injury after global ischemia in transgenic mice. Stroke 28, 1797-1804. doi: 10.1161/01.str.28.9.1797
51. Murphy, A., and Fiskum, G. (1999). Bcl-2 and Ca(2+)-mediated mitochondrial dysfunction in neural cell death. Biochem. Soc. Symp. 66, 33-41. doi: 10.1042/bss0660033
52. Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267. doi: 10.1126/science.272.5259.263
53. Otsuka, S., Sakakima, H., Sumizono, M., Takada, S., Terashi, T., and Yoshida, Y. (2016). The neuroprotective effects of preconditioning exercise on brain damage and neurotrophic factors after focal brain ischemia in rats. Behav. Brain Res. 303, 9-18. doi: 10.1016/j.bbr.2016.01.049
54. Paciaroni, M., Balucani, C., Agnelli, G., Caso, V., Silvestrelli, G., Grotta, J. C., et al. (2012). Systemic thrombolysis in patients with acute ischemic stroke and internal carotid ARtery occlusion: the ICARO study. Stroke 43, 125-130. doi: 10.1161/strokeaha.111.630624
55. Paciaroni, M., Inzitari, D., Agnelli, G., Caso, V., Balucani, C., Grotta, J. C., et al. (2015). Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study. J. Neurol. 262, 459-468. doi: 10.1007/s00415-014-7550-1
56. Ruscher, K., Kuric, E., Liu, Y., Walter, H. L., Issazadeh-Navikas, S., Englund, E., et al. (2013). Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke. J. Cereb. Blood Flow Metab. 33, 1225-1234. doi: 10.1038/jcbfm.2013.71
57. Saver, J. L., Goyal, M., Bonafe, A., Diener, H. C., Levy, E. I., Pereira, V. M., et al. (2015). Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N. Engl. J. Med. 372, 2285-2295. doi: 10.1056/NEJMoa1415061
58. Semkova, I., and Krieglstein, J. (1999). Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res. Rev. 30, 176-188. doi: 10.1016/S0165-0173(99)00013-2
59. Sugiura, S., Kitagawa, K., Tanaka, S., Todo, K., Omura-Matsuoka, E., Sasaki, T., et al. (2005). Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats. Stroke 36, 859-864. doi: 10.1161/01.str.0000158905.22871.95
60. Sun, H., Le, T., Chang, T. T. J., Habib, A., Wu, S., Shen, F., et al. (2011). AAVmediated netrin-1 overexpression increases peri-infarct blood vessel density and improves motor function recovery after experimental stroke. Neurobiol. Dis. 44, 73-83. doi: 10.1016/j.nbd.2011.06.006
61. Sun, Y., Jin, K., Clark, K. R., Peel, A., Mao, X. O., Chang, Q., et al. (2003). Adeno-associated virus-mediated delivery of BCL-w gene improves outcome after transient focal cerebral ischemia. Gene Ther. 10, 115-122. doi: 10.1038/sj.gt.3301868
62. Tabakman, R., Jiang, H., Shahar, I., Arien-Zakay, H., Levine, R., and Lazarovici, P. (2005). Neuroprotection by NGF in the PC12 in vitro OGD model: involvement of mitogen-activated protein kinases and gene expression. Ann. N. Y. Acad. Sci. 1053, 84-96. doi: 10.1196/annals.1344.008
63. Thrift, A. G., Cadilhac, D. A., Thayabaranathan, T., Howard, G., Howard, V. J., Rothwell, P. M., et al. (2014). Global stroke statistics. Int. J. Stroke 9, 6-18. doi: 10.1111/ijs.12245
64. Tsai, T., Chen, S., Xiao, X., Chiang, Y., Lin, S., Kuo, S., et al. (2003). Gene treatment of cerebral stroke by rAAV vector delivering IL-1ra in a rat model. Neuroreport 14, 803-807. doi: 10.1097/01.wnr.0000065732.03340.b5
65. Tsai, T. H., Chen, S. L., Chiang, Y. H., Lin, S. Z., Ma, H. I., Kuo, S. W., et al. (2000). Recombinant adeno-associated virus vector expressing glial cell linederived neurotrophic factor reduces ischemia-induced damage. Exp. Neurol. 166, 266-275. doi: 10.1006/exnr.2000.7505
66. Tsai, T. H., Chen, S. L., Xiao, X., Chiang, Y. H., and Tsao, Y. P. (2006). Gene therapy of focal cerebral ischemia using defective recombinant adeno-associated virus vectors. Front. Biosci. 11, 2061-2070. doi: 10.2741/1948
67. Tsuchiya, A., Hayashi, T., Deguchi, K., Sehara, Y., Yamashita, T., Zhang, H., et al. (2007). Expression of netrin-1 and its receptors DCC and neogenin in rat brain after ischemia. Brain Res. 1159, 1-7. doi: 10.1016/j.brainres.2006.12.096
68. van der Weerd, L., Tariq Akbar, M., Aron Badin, R., Valentim, L. M., Thomas, D. L., Wells, D. J., et al. (2010). Overexpression of heat shock protein 27 reduces cortical damage after cerebral ischemia. J. Cereb. Blood Flow Metab. 30, 849-856. doi: 10.1038/jcbfm.2009.249
69. von Jonquieres, G., Fröhlich, D., Klugmann, C. B., Wen, X., Harasta, A. E., Ramkumar, R., et al. (2016). Recombinant human myelin-associated glycoprotein promoter drives selective AAV-Mediated transgene expression in oligodendrocytes. Front. Mol. Neurosci. 9: 13. doi: 10.3389/fnmol.2016.00013
70. von Jonquieres, G., Mersmann, N., Klugmann, C. B., Harasta, A. E., Lutz, B., Teahan, O., et al. (2013). Glial promoter selectivity following AAV-delivery to the immature brain. PLoS One 8: e65646. doi: 10.1371/journal.pone.0065646
71. Wang, Y., Huang, J., Li, Y., and Yang, G. (2012). Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr. Drug Targets 13, 166-172. doi: 10.2174/138945012799201603
72. Watanabe, T., Okuda, Y., Nonoguchi, N., Zhao, M. Z., Kajimoto, Y., Furutama, D., et al. (2004). Postischemic intraventricular administration of FGF-2 expressing adenoviral vectors improves neurologic outcome and reduces infarct volume after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 24, 1205-1213. doi: 10.1097/01.wcb.0000136525.75839.41
73. Wong, L.-F., Ralph, G. S., Walmsley, L. E., Bienemann, A. S., Parham, S., Kingsman, S. M., et al. (2005). Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus. Mol. Ther. 11, 89-95. doi: 10.1016/j.ymthe.2004.08.026
74. Xu, L., Xiong, X., Ouyang, Y., Barreto, G., and Giffard, R. (2011). Heat shock protein 72 (Hsp72) improves long term recovery after focal cerebral ischemia in mice. Neurosci. Lett. 488, 279-282. doi: 10.1016/j.neulet.2010.11.047
75. Yenari, M. A., Dumas, T. C., Sapolsky, R. M., and Steinberg, G. K. (2001). Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors. Ann. N. Y. Acad. Sci. 939, 340-357. doi: 10.1111/j.1749-6632.2001.tb03643.x
76. Yenari, M. A., Fink, S. L., Sun, G. H., Chang, L. K., Patel, M. K., Kunis, D. M., et al. (1998). Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann. Neurol. 44, 584-591. doi: 10.1002/ana.410440403
77. Yoo, J., Seo, J., Eom, J., and Hwang, D. (2012). Effects of stromal cell-derived factor 1alpha delivered at different phases of transient focal ischemia in rats. Neuroscience 209, 171-186. doi: 10.1016/j.neuroscience.2012.02.031
78. Yuan, M., Wen, S., Yang, C., Pang, Y., Gao, X., Liu, X., et al. (2013). Transplantation of neural stem cells overexpressing glial cell line-derived neurotrophic factor enhances Akt and Erk1/2 signaling and neurogenesis in rats after stroke. Chin. Med. J. 126, 1302-1309.
79. Zhang, J., Yu, Z., Yu, Z., Yang, Z., Zhao, H., Liu, L., et al. (2011). rAAV-mediated delivery of brain-derived neurotrophic factor promotes neurite outgrowth and protects neurodegeneration in focal ischemic model. Int. J. Clin. Exp. Pathol. 4, 496-504.
80. Zhang, W. R., Sato, K., Iwai, M., Nagano, I., Manabe, Y., and Abe, K. (2002). Therapeutic time window of adenovirus-mediated GDNF gene transfer after transient middle cerebral artery occlusion in rat. Brain Res. 947, 140-145. doi: 10.1016/S0006-8993(02)02923-2
81. Zhang, Y., and Pardridge, W. M. (2001). Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system. Stroke 32, 1378-1384. doi: 10.1161/01.str.32.6.1378
82. Zhao, H., Yenari, M., Cheng, D., Barreto-Chang, O., Sapolsky, R., and Steinberg, G. (2004). Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J. Cereb. Blood Flow Metab. 24, 681-692. doi: 10.1097/01.wcb.0000127161.89708.a5
83. Zhao, H., Yenari, M. A., Cheng, D., Sapolsky, R. M., and Steinberg, G. K. (2003). Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J. Neurochem. 85, 1026-1036. doi: 10.1046/j.1471-4159.2003.01756.x
84. Zhao, S., Qu, H., Zhao, Y., Xiao, T., Zhao, M., Li, Y., et al. (2015). CXCR4 antagonist AMD3100 reverses the neurogenesis and behavioral recovery promoted by forced limb-use in stroke rats. Restor. Neurol. Neurosci. 33, 809-821. doi: 10.3233/rnn-150515
85. Zhong, L. T., Sarafian, T., Kane, D. J., Charles, A. C., Mah, S. P., Edwards, R. H., et al. (1993). bcl-2 inhibits death of central neural cells induced by multiple agents. Proc.Natl. Acad. Sci. U.S.A. 90, 4533-4537. doi: 10.1073/pnas.90.10.4533